What is GeneDx Holdings's cash ratio?

GeneDx Holdings (WGS) reported cash ratio of 1.1× in Q1 2026.

How has GeneDx Holdings's cash ratio changed year-over-year?

GeneDx Holdings's cash ratio decreased by 25.2% year-over-year, from 1.4× to 1.1×.

What is the long-term trend for GeneDx Holdings's cash ratio?

Over 5 years (2020 to 2025), GeneDx Holdings's cash ratio has grown at a -9.7% compound annual growth rate (CAGR), from 1.6× to 1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

GeneDx Holdings WGS Cash ratio

Cash ratio at other companies

Natera, Inc.NTRA

1.9×-0.7×

Tempus AI, Inc.TEM

1.7×+1.2×

Bio-Rad LaboratoriesBIO

0.6×-0.5×

Quest DiagnosticsDGX

0.2×0.0×

RevvityRVTY

0.7×-1.1×

Labcorp HoldingsLH

0.4×+0.2×

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

P/S3.9×-3.0×

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

cash and equivalents/total current liabilities=1.1×

Based on the most recent quarter.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's cash ratio?: GeneDx Holdings (WGS) reported cash ratio of 1.1× in Q1 2026.
How has GeneDx Holdings's cash ratio changed year-over-year?: GeneDx Holdings's cash ratio decreased by 25.2% year-over-year, from 1.4× to 1.1×.
What is the long-term trend for GeneDx Holdings's cash ratio?: Over 5 years (2020 to 2025), GeneDx Holdings's cash ratio has grown at a -9.7% compound annual growth rate (CAGR), from 1.6× to 1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.